These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15243283)

  • 1. Comparison of intranasal and transdermal estradiol on nasal mucosa in postmenopausal women.
    Nappi C; Di Spiezio Sardo A; Guerra G; Di Carlo C; Bifulco G; Acunzo G; Sammartino A; Galli V
    Menopause; 2004; 11(4):447-55. PubMed ID: 15243283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptidergic innervation of human nasal mucosa in various pathological conditions.
    Fang SY; Shen CL
    Proc Natl Sci Counc Repub China B; 1997 Jan; 21(1):8-12. PubMed ID: 9208481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
    Shulman LP; Yankov V; Uhl K
    Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin and peptide content of nerve fibers in the nasal mucosa of rats.
    Grunditz T; Uddman R; Sundler F
    Anat Embryol (Berl); 1994 Apr; 189(4):327-37. PubMed ID: 7521148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
    Archer DF; Furst K; Tipping D; Dain MP; Vandepol C
    Obstet Gynecol; 1999 Oct; 94(4):498-503. PubMed ID: 10511348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and quantity of neuroendocrine markers in allergic rhinitis.
    Fang SY; Shen CL; Ohyama M
    Acta Otolaryngol; 1998 Jun; 118(3):398-403. PubMed ID: 9655216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intranasal acupuncture on neurogenic inflammation in allergic rhinitis rabbits].
    Gong Z; Yan ZF; Liu QP; Liu LL; Liu SM; Jiao LL; Bian FZ; Zhang LJ; Zhang LL
    Zhen Ci Yan Jiu; 2021 Feb; 46(2):111-6. PubMed ID: 33788431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis.
    Fang SY; Shen CL
    Clin Exp Allergy; 1998 Feb; 28(2):228-32. PubMed ID: 9515597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M; Kenemans P; de Bie L; van de Weijer PH; van der Mooren MJ
    Fertil Steril; 2006 Apr; 85(4):979-88. PubMed ID: 16580384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of nasal epithelial cells in naturally postmenopausal women receiving hormone therapy with 1 mg 17beta-estradiol and 2 mg drospirenone: a prospective study.
    Caruso S; Serra A; Grillo C; Maiolino L; Agnello C; Di Mari L; Cianci A
    Menopause; 2008; 15(5):963-6. PubMed ID: 18391834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
    Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
    Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
    Slater CC; Hodis HN; Mack WJ; Shoupe D; Paulson RJ; Stanczyk FZ
    Menopause; 2001; 8(3):200-3. PubMed ID: 11355042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
    Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.